Chung Christine's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Jun 15, 2023
- Accession no.
- 0001209191-23-037604
- Filed
- Jun 15, 2023
- Trade date
- Jun 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $214.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chung ChristineCIK 0001775295 | Officer (SVP, China Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | SSaleDisposed | −6,250 | $17.60 | −$110,000 | 242,577 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −5,250 | $16.66 | −$87,465 | 237,327 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −1,000 | $17.46 | −$17,460 | 236,327 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.